These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37650264)

  • 21. The Cardiology Society of India-Kerala Acute Heart Failure Registry: poor adherence to guideline-directed medical therapy.
    Joseph S; Panniyammakal J; Abdullakutty J; S S; Vaikathuseril L J; Joseph J; Mattummal S; Punnose E; Unni G; Natesan S; Sivadasanpillai H
    Eur Heart J; 2021 Dec; ():. PubMed ID: 34931232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescription Rates and Prognostic Implications of Optimally Targeted Guideline-Directed Medical Treatment in Heart Failure and Atrial Fibrillation: Insights From The MISOAC-AF Trial.
    Moysidis DV; Kartas A; Samaras A; Papazoglou AS; Patsiou V; Bekiaridou A; Baroutidou A; Tsagkaris C; Karagiannidis E; Daios S; Anastasiou V; Tsalikakis D; Efthimiadis G; Ziakas A; Tzikas A; Giannakoulas G
    J Cardiovasc Pharmacol; 2023 Mar; 81(3):203-211. PubMed ID: 36626410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex-specific differences in the efficacy of heart failure therapies: a meta-analysis of 84,818 patients.
    Wang N; Evans J; Sawant S; Sindone J; Lal S
    Heart Fail Rev; 2023 Jul; 28(4):949-959. PubMed ID: 36198840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
    Martin N; Manoharan K; Thomas J; Davies C; Lumbers RT
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012721. PubMed ID: 29952095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guideline Directed Medical Therapy at Discharge and Further Uptitration Leading to Reduction in Indication for Prophylactic ICD Implantation during Protected Waiting Period.
    Waezsada E; Hutter J; Kahle P; Yogarajah J; Sperzel J; Kuniss M; Neumann T; Esser H; Hamm C; Hain A
    J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation: The COAPT Trial.
    Cox ZL; Zalawadiya SK; Simonato M; Redfors B; Zhou Z; Kotinkaduwa L; Zile MR; Udelson JE; Lim DS; Grayburn PA; Mack MJ; Abraham WT; Stone GW; Lindenfeld J
    JACC Heart Fail; 2023 Jul; 11(7):791-805. PubMed ID: 37115135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
    Martin N; Manoharan K; Davies C; Lumbers RT
    Cochrane Database Syst Rev; 2021 May; 5(5):CD012721. PubMed ID: 34022072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Guideline Directed Medical Therapy Doses and Optimization in Patients Hospitalized With Decompensated Systolic Heart Failure.
    Grewal D; Partow-Navid R; Garcia D; Coney J; Fraser G; Stoletniy L; Sakr A; Parwani P; Abramov D
    Am J Cardiol; 2021 Jul; 151():64-69. PubMed ID: 34167690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medication and Outcome in Older Heart Failure Patients: Results from a Prospective Cohort Study.
    Garay DP; Saner H; Herzberg J; Hellige G; Arenja N
    Pharmaceuticals (Basel); 2024 May; 17(6):. PubMed ID: 38931378
    [No Abstract]   [Full Text] [Related]  

  • 30. Medical Therapy During Hospitalization for Heart Failure With Reduced Ejection Fraction: The VICTORIA Registry.
    Greene SJ; Ezekowitz JA; Anstrom KJ; Demyanenko V; Givertz MM; Piña IL; O'Connor CM; Koglin J; Roessig L; Hernandez AF; Armstrong PW; Mentz RJ
    J Card Fail; 2022 Jul; 28(7):1063-1077. PubMed ID: 35301107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guideline-Directed Medical Therapy in Newly Diagnosed Heart Failure With Reduced Ejection Fraction in the Community.
    Dunlay SM; Killian JM; Roger VL; Schulte PJ; Blecker SB; Savitz ST; Redfield MM
    J Card Fail; 2022 Oct; 28(10):1500-1508. PubMed ID: 35902033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure: The REVEAL-HF Randomized Clinical Trial.
    Ahmad T; Desai NR; Yamamoto Y; Biswas A; Ghazi L; Martin M; Simonov M; Dhar R; Hsiao A; Kashyap N; Allen L; Velazquez EJ; Wilson FP
    JAMA Cardiol; 2022 Sep; 7(9):905-912. PubMed ID: 35947362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remote Optimization of Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
    Desai AS; Maclean T; Blood AJ; Bosque-Hamilton J; Dunning J; Fischer C; Fera L; Smith KV; Wagholikar K; Zelle D; Gaziano T; Plutzky J; Scirica B; MacRae CA
    JAMA Cardiol; 2020 Dec; 5(12):1430-1434. PubMed ID: 32936209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Guideline-Directed Medical Therapy for Outpatients Living with Heart Failure with Reduced Ejection Fraction.
    McVannel T; Albers L; Kosar L; Reid B; Yeung C; Siddiqui M; Baran O
    Can J Hosp Pharm; 2024; 77(1):e3373. PubMed ID: 38482388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Computable Algorithm for Medication Optimization in Heart Failure With Reduced Ejection Fraction.
    Dorsch MP; Sifuentes A; Cordwin DJ; Kuo R; Rowell BE; Arzac JJ; DeBacker K; Guidi JL; Hummel SL; Koelling TM
    JACC Adv; 2023 May; 2(3):100289. PubMed ID: 38939592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cluster-Randomized Trial Comparing Ambulatory Decision Support Tools to Improve Heart Failure Care.
    Mukhopadhyay A; Reynolds HR; Phillips LM; Nagler AR; King WC; Szerencsy A; Saxena A; Aminian R; Klapheke N; Horwitz LI; Katz SD; Blecker S
    J Am Coll Cardiol; 2023 Apr; 81(14):1303-1316. PubMed ID: 36882134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry.
    Greene SJ; Butler J; Hellkamp AS; Spertus JA; Vaduganathan M; Devore AD; Albert NM; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC
    J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
    ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-Hospital Virtual Peer-to-Peer Consultation to Increase Guideline-Directed Medical Therapy for Heart Failure: A Pilot Randomized Trial.
    Rao VN; Shah A; McDermott J; Barnes SG; Murray EM; Kelsey MD; Greene SJ; Fudim M; DeVore AD; Patel CB; Blazing MA; O'Brien C; Mentz RJ
    Circ Heart Fail; 2023 Feb; 16(2):e010158. PubMed ID: 36314130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient Perceptions and Familiarity With Medical Therapy for Heart Failure.
    Samsky MD; Lin L; Greene SJ; Lippmann SJ; Peterson PN; Heidenreich PA; Laskey WK; Yancy CW; Greiner MA; Hardy NC; Kavati A; Park S; Mentz RJ; Fonarow GC; O'Brien EC
    JAMA Cardiol; 2020 Mar; 5(3):292-299. PubMed ID: 31734700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.